Patent US3248294A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3248294A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel 13belta-alkyl-4, 9, 11-gonatriene-3-ones

Assignee: Sanofi Aventis France
•
Filing: 1964-09-18
•
Granted: 1966-04-26
•
Expires: 1984-09-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Nomine Gerard
  • 👤 Bucourt Robert
  • 👤 Pierdet Andre

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 17:23
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/565; A61K31/567; A23; A23K; A23K20/00; A23K20/10; A23K20/168; A61K31/566; C; C07; C07J; C07J1/00; C07J41/00; C07J75/00; C07C; C07C2603/00; C07C2603/02; C07C2603/04; C07C2603/06; C07C2603/10; C07C2603/12; C07C2603/16

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 16 words
A COMPOSITION HAVING ANABOLIC ACTIVITY COMPRISING 0.10 TO 50 MG. OF A GONATRIENE OF THE FORMULA
Claim 2
Dependent Claim 16 words
A COMPOSITION HAVING ANABOLIC ACTIVITY COMPRISING 0.10 TO 50 MG. OF A GONATRIENE OF THE FORMULA

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1969-04-25 1969-10-25 1970-04-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1973-04-25 1973-10-25 1974-04-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1977-04-25 1977-10-25 1978-04-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag